(Reuters) - Japan's Takeda Pharmaceutical Co said on Thursday it had started regulatory submissions to Europe's health regulator for its dengue vaccine candidate, which is being developed for individuals aged four to 60. The drugmaker ...
from Google Alert - health https://ift.tt/2NTXi29
via IFTTT
0 comments:
Post a Comment